Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 26:11:3451-9.
doi: 10.2147/IJN.S105420. eCollection 2016.

Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer

Affiliations

Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer

Na Qu et al. Int J Nanomedicine. .

Abstract

Cabazitaxel-loaded human serum albumin nanoparticles (Cbz-NPs) were synthesized to overcome vehicle-related toxicity of current clinical formulation of the drug based on Tween-80 (Cbz-Tween). A salting-out method was used for NP synthesis that avoids the use of chlorinated organic solvent and is simpler compared to the methods based on emulsion-solvent evaporation. Cbz-NPs had a narrow particle size distribution, suitable drug loading content (4.9%), and superior blood biocompatibility based on in vitro hemolysis assay. Blood circulation, tumor uptake, and antitumor activity of Cbz-NPs were assessed in prostatic cancer xenograft-bearing nude mice. Cbz-NPs exhibited prolonged blood circulation and greater accumulation of Cbz in tumors along with reduced toxicity compared to Cbz-Tween. Moreover, hematoxylin and eosin histopathological staining of organs revealed consistent results. The levels of blood urea nitrogen and serum creatinine in drug-treated mice showed that Cbz-NPs were less toxic than Cbz-Tween to the kidneys. In conclusion, Cbz-NPs provide a promising therapeutic for prostate cancer.

Keywords: cabazitaxel; drug delivery; human serum albumin; nanoparticle; prostate cancer; toxicity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Physicochemical characterization of Cbz-NPs. Notes: (A) A schematic diagram of Cbz-NPs preparation. (B) Lyophilized NPs. (C) NPs redissolved in saline. (D) SEM image of Cbz-NPs. Abbreviations: Cbz-NPs, cabazitaxel-loaded human serum albumin nanoparticles; HSA, human serum albumin; SEM, scanning electron microscopy.
Figure 2
Figure 2
In vitro hemolysis assay of Cbz-Tween and Cbz-NPs. Notes: (A) HR (%) of various concentration of Cbz. (B) Images of RBCs treated with Cbz-Tween or Cbz-NPs. Data are expressed as mean ± SE (n=3). **P<0.01; ***P<0.001. Abbreviations: Cbz-NPs, cabazitaxel-loaded human serum albumin nanoparticles; HR (%), hemolysis ratio; RBC, red blood cells; SE, standard error.
Figure 3
Figure 3
The mean plasma concentration–time profiles for Cbz. Notes: (A) The concentration–time curve of Cbz in rat plasma after Cbz-NPs and Cbz-Tween administration. (B) The subtle differences at early time points are shown as an inset. Abbreviations: Cbz-NPs, cabazitaxel-loaded human serum albumin nanoparticles; h, hours.
Figure 4
Figure 4
Tissue distribution of Cbz to the organs after treatments with either Cbz-NPs or Cbz-Tween. Notes: (A) Heart, (B) liver, (C) spleen, (D) lung, (E) kidney, and (F) tumor. Data are expressed as mean ± SE (n=6). **P<0.01. Abbreviations: Cbz-NPs, cabazitaxel-loaded human serum albumin nanoparticles; h, hours; SE, standard error.
Figure 5
Figure 5
Antitumor activity of Cbz-NPs treatment on prostate cancer tumor-bearing mice compared to Cbz-Tween treatment. Notes: (A) Body weight of the mice during the experiment. (B) Antitumor effect of Cbz-NPs and Cbz-Tween tumor-bearing mice. (C) Images of the nude mice after intravenous injections of Cbz-Tween and Cbz-NPs, saline was used as a control. Data are expressed as mean ± SE (n=7). **P<0.01; ***P<0.001. Abbreviations: Cbz-NPs, cabazitaxel-loaded human serum albumin nanoparticles; SE, standard error.
Figure 6
Figure 6
The pathological hematoxylin and eosin staining analysis of tissue sections. Note: Arrows were used to indicate relevant areas of fat liver and spleen infiltration. Abbreviation: Cbz-NPs, cabazitaxel-loaded human serum albumin nanoparticles.

Similar articles

Cited by

References

    1. Mellado B, Jimenez N, Marin-Aguilera M, Reig O. Diving into cabazitaxel mode of action; more than a taxane for the treatment of castration resistance prostate cancer patients. Clin Genitourin Cancer. 2015 Dec 28; Epub. - PubMed
    1. Zhuang B, Du L, Xu H, et al. Self-assembled micelle loading cabazitaxel for therapy of lung cancer. Int J Pharm. 2016;499(1–2):146–155. - PubMed
    1. Moriceau G, Guillot A, Pacaut C, et al. Translating clinical evidence-based medicine into the real world: single-center experience with cabazitaxel in metastatic prostate cancer patients. Chemotherapy. 2016;61(3):127–133. - PubMed
    1. He Z, Schulz A, Wan X, et al. Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation. J Control Release. 2015;208:67–75. - PMC - PubMed
    1. Coors EA, Seybold H, Merk HF, Mahler V. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Ann Allergy Asthma Immunol. 2005;95(6):593–599. - PubMed

MeSH terms